The study published in the Lancet on April 30 was the outcome of research, which was funded in part by the China's government ...

Their approach, based on continuous glucose monitoring (CGM) data, could improve early detection and risk assessment for diabetes without relying on blood samples and expensive or complex procedures.

Scientists have identified a simple, noninvasive method for assessing blood glucose regulation using continuous glucose monitoring (CGM) data. Their approach, which tracks glucose fluctuations, ...

Their approach, based on continuous glucose monitoring (CGM) data, could improve early detection and risk assessment for diabetes without relying on blood samples and expensive or complex procedures.

An investigational blood test for type 1 diabetes can accurately detect the disorder's characteristic autoimmunity with only ...

AI technologies hold immense potential to transform diabetes self-care by improving monitoring, enabling personalized ...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the U.S. Food and Drug Administration ...

This pilot study provides essential insights into how AI can augment traditional clinical workflows in diabetes management by ...

Researchers at The University of Queensland have dosed 5 participants in the first clinical trial of a potentially ...